A prolyl oligopeptidase inhibitor, Z-Pro-Prolinal, inhibits glyceraldehyde-3-phosphate dehydrogenase translocation and production of reactive oxygen species in CV1-P cells exposed to 6-hydroxydopamine

被引:35
作者
Puttonen, Katja A.
Lehtonen, Sarka
Raasmaja, Atso
Mannisto, Pekka T.
机构
[1] Univ Kuopio, Dept Pharmacol & Toxicol, FIN-70211 Kuopio, Finland
[2] Univ Helsinki, Inst Biomed Pharmacol, FIN-00014 Helsinki, Finland
[3] Univ Helsinki, Div Pharmacol & Toxicol, FIN-00014 Helsinki, Finland
基金
芬兰科学院;
关键词
glyceraldehyde-3-phosphate dehydrogenase (GAPDH); prolyl oligopeptidase (POP) inhibitor; 6-hydroxydopamine (6-OHDA); apoptosis;
D O I
10.1016/j.tiv.2006.07.001
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
We studied the ability of prolyl oligopeptidase (POP) inhibitors, Z-Pro-Prolinal and JTP-4819, to prevent translocation of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and formation of reactive oxygen species (ROS), in 6-hydroxydopamine (6-OHDA) and cytosine arabinoside (Ara-C) treated monkey fibroblast (CV1-P) and human neuroblastoma (SH-SY5Y) cells. The cells were pretreated with POP inhibitors (30 min) before addition of toxicants. GAPDH was analyzed by Western hybridization, ROS by fluorescent 27-dichlorodihydro-fluorescein diacetate, and viability by the MTT method. Both toxicants induced GAPDH translocation to the particulate fraction (mitochondria and nuclei). Z-Pro-Prolinal was able to inhibit the translocation in 6-OHDA-exposed CV1-P cells. In SH-SY5Y cells and in JTP-4819 pretreated cells, no prevention of translocation was seen. However, the intensity of GAPDH in cytosolic fraction increased. Both inhibitors blocked 6-OHDA-induced ROS-production to the control level in CV1-P but, not in SH-SY5Y cells, without affecting their viability. In conclusion, POP inhibitors are able to prevent certain cell stress related factors such as ROS production or GAPDH translocation. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1446 / 1454
页数:9
相关论文
共 39 条
[1]   DEFICIENCY OF KALLIKREIN-LIKE ENZYME-ACTIVITIES IN CEREBRAL TISSUE OF PATIENTS WITH ALZHEIMERS-DISEASE [J].
AOYAGI, T ;
WADA, T ;
NAGAI, M ;
KOJIMA, F ;
HARADA, S ;
TAKEUCHI, T ;
TAKAHASHI, H ;
HIROKAWA, K ;
TSUMITA, T .
EXPERIENTIA, 1990, 46 (01) :94-97
[2]  
Berry MD, 2000, J NEUROSCI RES, V60, P150, DOI 10.1002/(SICI)1097-4547(20000415)60:2<150::AID-JNR3>3.0.CO
[3]  
2-4
[4]   Cytochrome c binds to inositol (1,4,5) trisphosphate receptors, amplifying calcium-dependent apoptosis [J].
Boehning, D ;
Patterson, RL ;
Sedaghat, L ;
Glebova, NO ;
Kurosaki, T ;
Snyder, SH .
NATURE CELL BIOLOGY, 2003, 5 (12) :1051-1061
[5]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[6]   Huntington and DRPLA proteins selectively interact with the enzyme GAPDH [J].
Burke, JR ;
Enghild, JJ ;
Martin, ME ;
Jou, YS ;
Myers, RM ;
Roses, AD ;
Vance, JM ;
Strittmatter, WJ .
NATURE MEDICINE, 1996, 2 (03) :347-350
[7]   Glyceraldehyde-3-phosphate dehydrogenase, apoptosis and neurodegenerative diseases [J].
Chuang, DM ;
Hough, C ;
Senatorov, VV .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2005, 45 :269-+
[8]   A prolyl endopeptidase-inhibiting antioxidant from Phyllanthus ussurensis [J].
Chung, SK ;
Nam, JA ;
Jeon, SY ;
Kim, SI ;
Lee, HJ ;
Chung, TH ;
Song, KS .
ARCHIVES OF PHARMACAL RESEARCH, 2003, 26 (12) :1024-1028
[9]  
Dastoor Z, 2001, J CELL SCI, V114, P1643
[10]   Mitochondrial dysfunction, apoptotic cell death, and Alzheimer's disease [J].
Eckert, A ;
Keil, U ;
Marques, CA ;
Bonert, A ;
Frey, C ;
Schüssel, K ;
Müller, WE .
BIOCHEMICAL PHARMACOLOGY, 2003, 66 (08) :1627-1634